Open AccessInhaled glucocorticosteroids in treatment of chronic obstructive pulmonary disease/
Author(s) -
A.G. Romanovskikh Romanovskikh,
Yu.G. Belotserkovskaya Belotserkovskaya,
I.P. Smirnov Smirnov
Publication year - 2018
Publication title -
kliničeskaâ medicina
Language(s) - English
Resource type - Journals
eISSN - 2412-1339
pISSN - 0023-2149
DOI - 10.18821/0023-2149-2018-96-3-257-261
Subject(s) - copd , medicine , pulmonary disease , inhaled corticosteroids , intensive care medicine , asthma
Chronic obstructive pulmonary disease (COPD) is an urgent problem of modern healthcare. One of the most frequent approaches to the therapy of the COPD remains the appointment of inhaled corticosteroids (ICSs) and long-acting β2-agonists (LABAs) in fixed-dose combinations. At the same time, the role and place of fixed-dose combinations (ICS/LABA) in COPD therapy is currently being actively discussed. The presented article describes the efficacy and safety of fixed-dose combinations (ICS/LABA) in COPD patients, modern approaches to the appointment of ICS/LABA.